Shares of Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) rose 5.1% during mid-day trading on Wednesday . The stock traded as high as $4.73 and last traded at $4.55. Approximately 55,136 shares traded hands during trading, a decline of 59% from the average daily volume of 136,076 shares. The stock had previously closed at $4.33.
Elevai Labs Stock Performance
The firm has a market cap of $2.63 million, a PE ratio of -0.07 and a beta of -2.95. The stock has a 50-day moving average price of $8.94 and a 200 day moving average price of $53.30. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.86 and a quick ratio of 3.40.
About Elevai Labs
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
Read More
- Five stocks we like better than Elevai Labs
- Dividend Capture Strategy: What You Need to Know
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Stock Average Calculator
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Find and Profitably Trade Stocks at 52-Week Lows
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
